4//SEC Filing
Farrow Jeffrey S 4
Accession 0001819790-25-000047
CIK 0001819790other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 9:40 PM ET
Size
7.1 KB
Accession
0001819790-25-000047
Insider Transaction Report
Form 4
Farrow Jeffrey S
See Remarks
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-03-17−8,019→ 24,060 total→ Common Stock (8,019 underlying) - Exercise/Conversion
Common Stock
2025-03-15+8,019→ 26,155 total
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs").
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]RSUs granted on March 7, 2024, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on March 15th of each of 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001405253
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 9:40 PM ET
- Size
- 7.1 KB